Transvaginal and transobturator autologous vaginal tape cystocele treatment: About an uncommon case.
Autologous vaginal tape
Cystocele
Pelvic organ prolapse
Journal
International journal of surgery case reports
ISSN: 2210-2612
Titre abrégé: Int J Surg Case Rep
Pays: Netherlands
ID NLM: 101529872
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
17
03
2022
revised:
10
05
2022
accepted:
11
05
2022
pubmed:
3
6
2022
medline:
3
6
2022
entrez:
2
6
2022
Statut:
ppublish
Résumé
Pelvic organ prolapse (POP) significantly impairs women's quality of life. The literature reports that nearly one in five women will require surgery in their lifetime, and nearly 40.6% involve anterior wall repair, specifically cystocele. Several techniques and surgical approaches have been used for cystocele management. These were performed by transvaginal and/or transabdominal approach and involved the use of native tissue or prosthesis. Nevertheless, since the transvaginal mesh ban recommended by the FDA and learned societies, autologous tissue repair has become the cornerstone of all vaginal prolapse surgery. We hereby present the case of a 71-year-old widow who had undergone three vaginal deliveries. The patient reported that she no longer had sexual intercourse. The preoperative functional signs observed included: stress urinary incontinence, urinary urgency, dysuria and disabling vaginal ball feeling. The management strategy chosen in consultation with the patient was a repair using autologous material via the vaginal route. The vaginal strips were passed through trans-obturator and retro pubic route allowed support of the bladder. This technique using autologous material was easy, fast and inexpensive. It was developed on the basis of the TVT and TOT techniques and stood out for its tolerance and long-lasting functional effectiveness. It avoids all the complications due to polypropylene trans-vaginal prostheses that led to the banning of trans-vaginal mesh.
Sections du résumé
BACKGROUND
BACKGROUND
Pelvic organ prolapse (POP) significantly impairs women's quality of life. The literature reports that nearly one in five women will require surgery in their lifetime, and nearly 40.6% involve anterior wall repair, specifically cystocele. Several techniques and surgical approaches have been used for cystocele management. These were performed by transvaginal and/or transabdominal approach and involved the use of native tissue or prosthesis. Nevertheless, since the transvaginal mesh ban recommended by the FDA and learned societies, autologous tissue repair has become the cornerstone of all vaginal prolapse surgery.
CASE PRESENTATION
METHODS
We hereby present the case of a 71-year-old widow who had undergone three vaginal deliveries. The patient reported that she no longer had sexual intercourse. The preoperative functional signs observed included: stress urinary incontinence, urinary urgency, dysuria and disabling vaginal ball feeling. The management strategy chosen in consultation with the patient was a repair using autologous material via the vaginal route. The vaginal strips were passed through trans-obturator and retro pubic route allowed support of the bladder.
CONCLUSIONS
CONCLUSIONS
This technique using autologous material was easy, fast and inexpensive. It was developed on the basis of the TVT and TOT techniques and stood out for its tolerance and long-lasting functional effectiveness. It avoids all the complications due to polypropylene trans-vaginal prostheses that led to the banning of trans-vaginal mesh.
Identifiants
pubmed: 35653945
pii: S2210-2612(22)00444-8
doi: 10.1016/j.ijscr.2022.107198
pmc: PMC9160734
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
107198Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Références
Int Urogynecol J. 2019 Oct;30(10):1725-1733
pubmed: 30506182
Int Urogynecol J Pelvic Floor Dysfunct. 1998;9(4):210-3
pubmed: 9795826
Trials. 2020 Jul 8;21(1):624
pubmed: 32641096
Lancet. 2019 Apr 27;393(10182):1686
pubmed: 31034366
Eur Urol. 1998;33(3):298-302
pubmed: 9555556
Int Urogynecol J. 2014 Mar;25(3):387-92
pubmed: 24121938
Female Pelvic Med Reconstr Surg. 2019 May-Jun;25(3):206-212
pubmed: 29300253
Int Urogynecol J. 2020 Nov;31(11):2435-2438
pubmed: 32494957
Int Urogynecol J. 2015 Jan;26(1):49-55
pubmed: 24842118
Br J Urol. 1983 Dec;55(6):687-90
pubmed: 6360297
Prog Urol. 2001 Dec;11(6):1306-13
pubmed: 11859672
Asia Oceania J Obstet Gynaecol. 1988 Mar;14(1):31-6
pubmed: 3377716
Int J Surg. 2020 Dec;84:226-230
pubmed: 33181358